by InfluencER | Mar 8, 2022 | Pharma
For more than half a century, federal law stopped all private-sector companies from selling Schedule I drug for medical research. But York County-based Groff North America said it became the first business in the country last month to bring a cannabis crop to market...
by InfluencER | Mar 8, 2022 | Pharma
Slowly, but surely, the U.S. Drug Enforcement Administration is rolling out licenses to entities that want federal permission to grow cannabis for research. For more than fifty years, only one place could legally do so: the University of Mississippi. Then in 2016, the...
by InfluencER | Feb 10, 2022 | Pharma
A recent op-ed concerning high-potency cannabis products opened with: “As more of us reveal our stories, more families are empowered to share theirs, as well.” That inspired me to share my family’s story. Access to therapeutically concentrated cannabis saved my life....
by InfluencER | Feb 8, 2022 | Pharma
PHARMACEUTICALRX, one of the largest producers of premium organic medical marijuana products in the US market, today announced that it has closed a $34 million senior secured term loan (the “Senior Term Loan”) provided by Chicago Atlantic Real Estate Finance,...
by InfluencER | Feb 1, 2022 | Pharma
Marijuana is the most used illicit substance globally, with roughly 90 million individuals in Europe alone having used the drug once in their lifetime. Recently, scientists from the Karolinska Institute in Stockholm conducted a study to determine whether changes in...
by InfluencER | Jan 25, 2022 | Pharma
Royal Emerald Pharmaceuticals (REP) is proud to announce that it has received four federal licenses to grow, research, develop, and manufacture alternative drugs derived from cannabis (marijuana) and other botanicals in December 2021. REP is the first-of-its-kind...
